SEC Form 4 · accession 0001209191-16-092135
Alexza Pharmaceuticals Inc. · ALXA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark K Oki
Officer — Former SVP, CFO, Secretary
Period of report
Oct 16, 2015
Accepted (ET)
Jan 19, 2016 · 5:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001344413
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 13,713 | D |
Table II — derivative securities
No Table II lines on this filing.